共查询到20条相似文献,搜索用时 15 毫秒
1.
Abhijit Sen Nikos Papadimitriou Pagona Lagiou Aurora Perez-Cornago Ruth C. Travis Timothy J. Key Neil Murphy Marc Gunter Heinz Freisling Ioanna Tzoulaki David C. Muller Amanda J. Cross David S. Lopez Manuela Bergmann Heiner Boeing Christina Bamia Anastasia Kotanidou Anna Karakatsani Anne Tjønneland Cecilie Kyrø Malene Outzen María-Luisa Redondo Valerie Cayssials Maria-Dolores Chirlaque Aurelio Barricarte Maria-Jose Sánchez Nerea Larrañaga Rosario Tumino Sara Grioni Domenico Palli Saverio Caini Carlotta Sacerdote Bas Bueno-de-Mesquita Tilman Kühn Rudolf Kaaks Lena Maria Nilsson Rikard Landberg Peter Wallström Isabel Drake Bodil Hammer Bech Kim Overvad Dagfinn Aune Kay-Tee Khaw Elio Riboli Dimitrios Trichopoulos Antonia Trichopoulou Konstantinos K. Tsilidis 《International journal of cancer. Journal international du cancer》2019,144(2):240-250
The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 vs. 12 mL/day) the HRs were 1.02 (95% CI, 0.94–1.09) and 0.98 (95% CI, 0.90–1.07) for risk of total prostate cancer and 0.97 (95% CI, 0.79–1.21) and 0.89 (95% CI, 0.70–1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages. 相似文献
2.
Iris Cervenka Marie Al Rahmoun Yahya Mahamat-Saleh Agnès Fournier Marie-Christine Boutron-Ruault Gianluca Severi Saverio Caini Domenico Palli Reza Ghiasvand Marit B. Veierod Edoardo Botteri Anne Tjønneland Anja Olsen Renée T. Fortner Rudolf Kaaks Matthias B. Schulze Salvatore Panico Antonia Trichopoulou Clio Dessinioti Katerina Niforou Sabina Sieri Rosario Tumino Carlotta Sacerdote Bas Bueno-de-Mesquita Torkjel M. Sandanger Sandra Colorado-Yohar Maria J. Sánchez Leire Gil Majuelo Leila Lujan-Barroso Eva Ardanaz Susana Merino Karolin Isaksson Salma Butt Ingrid Ljuslinder Malin Jansson Ruth C. Travis Kay-Tee Khaw Elisabete Weiderpass Laure Dossus Sabina Rinaldi Marina Kvaskoff 《International journal of cancer. Journal international du cancer》2020,146(12):3267-3280
Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country-specific self-administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline-significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations. 相似文献
3.
S Rohrmann J Linseisen N Allen H B Bueno-de-Mesquita N F Johnsen A Tj?nneland K Overvad R Kaaks B Teucher H Boeing T Pischon P Lagiou A Trichopoulou D Trichopoulos D Palli Vittorio Krogh R Tumino F Ricceri M V Argüelles Suárez A Agudo M-J Sánchez M-D Chirlaque A Barricarte N Larra?aga H Boshuizen H J van Kranen P Stattin M Johansson A Bjartell D Ulmert K-T Khaw N J Wareham Pietro Ferrari I Romieux M J R Gunter Elio Riboli T J Key 《British journal of cancer》2013,108(3):708-714
Background:
Smoking is not associated with prostate cancer incidence in most studies, but associations between smoking and fatal prostate cancer have been reported.Methods:
During 1992 and 2000, lifestyle information was assessed via questionnaires and personal interview in a cohort of 145 112 European men. Until 2009, 4623 incident cases of prostate cancer were identified, including 1517 cases of low-grade, 396 cases of high grade, 1516 cases of localised, 808 cases of advanced disease, and 432 fatal cases. Multivariable Cox proportional hazards regression models were used to examine the association of smoking status, smoking intensity, and smoking duration with the risk of incident and fatal prostate cancer.Results:
Compared with never smokers, current smokers had a reduced risk of prostate cancer (RR=0.90, 95% CI: 0.83–0.97), which was statistically significant for localised and low-grade disease, but not for advanced or high-grade disease. In contrast, heavy smokers (25+ cigarettes per day) and men who had smoked for a long time (40+ years) had a higher risk of prostate cancer death (RR=1.81, 95% CI: 1.11–2.93; RR=1.38, 95% CI: 1.01–1.87, respectively).Conclusion:
The observation of an increased prostate cancer mortality among heavy smokers confirms the results of previous prospective studies. 相似文献4.
Steindorf K Friedenreich C Linseisen J Rohrmann S Rundle A Veglia F Vineis P Johnsen NF Tjønneland A Overvad K Raaschou-Nielsen O Clavel-Chapelon F Boutron-Ruault MC Schulz M Boeing H Trichopoulou A Kalapothaki V Koliva M Krogh V Palli D Tumino R Panico S Monninkhof E Peeters PH Boshuizen HC Bueno-de-Mesquita HB Chirlaque MD Agudo A Larrañaga N Quirós JR Martínez C Barricarte A Janzon L Berglund G Bingham S Khaw KT Key TJ Norat T Jenab M Cust A Riboli E 《International journal of cancer. Journal international du cancer》2006,119(10):2389-2397
Research conducted predominantly in male populations on physical activity and lung cancer has yielded inconsistent results. We examined this relationship among 416,277 men and women from the European Prospective Investigation into Cancer and Nutrition (EPIC). Detailed information on recent recreational, household and occupational physical activity, smoking habits and diet was assessed at baseline between 1992 and 2000. Relative risks (RR) were estimated using Cox regression. During 6.3 years of follow-up we identified 607 men and 476 women with incident lung cancer. We did not observe an inverse association between recent occupational, recreational or household physical activity and lung cancer risk in either males or females. However, we found some reduction in lung cancer risk associated with sports in males (adjusted RR = 0.71; 95% confidence interval 0.50-0.98; highest tertile vs. inactive group), cycling (RR = 0.73; 0.54-0.99) in females and non-occupational vigorous physical activity. For occupational physical activity, lung cancer risk was increased for unemployed men (adjusted RR = 1.57; 1.20-2.05) and men with standing occupations (RR = 1.35; 1.02-1.79) compared with sitting professions. There was no evidence of heterogeneity of physical activity associations across countries, or across any of the considered cofactors. For some histologic subtypes suggestive sex-specific reductions, limited by subgroup sizes, were observed, especially with vigorous physical activity. In total, our study shows no consistent protective associations of physical activity with lung cancer risk. It can be assumed that the elevated risks found for occupational physical activity are not produced mechanistically by physical activity itself but rather reflect exposure to occupation-related lung cancer risk factors. 相似文献
5.
Bjerregaard BK Raaschou-Nielsen O Sørensen M Frederiksen K Christensen J Tjønneland A Overvad K Chapelon FC Nagel G Chang-Claude J Bergmann MM Boeing H Trichopoulos D Trichopoulou A Oikonomou E Berrino F Palli D Tumino R Vineis P Panico S Peeters PH Bueno-de-Mesquita HB Kiemeney L Gram IT Braaten T Lund E Gonzalez CA Berglund G Allen N Roddam A Bingham S Riboli E 《International journal of cancer. Journal international du cancer》2006,119(10):2412-2416
The purpose of the present study was to investigate the association between smoking and the development of bladder cancer. The study population consisted of 429,906 persons participating in the European Prospective Investigation into Cancer and Nutrition (EPIC), 633 of whom developed bladder cancer during the follow-up period. An increased risk of bladder cancer was found for both current- (incidence rate ratio 3.96, 95% confidence interval: 3.07-5.09) and ex- (2.25, 1.74-2.91) smokers, compared to never-smokers. A positive association with intensity (per 5 cigarettes) was found among current-smokers (1.18, 1.09-1.28). Associations (per 5 years) were observed for duration (1.14, 1.08-1.21), later age at start (0.75, 0.66-0.85) and longer time since quitting (0.92, 0.86-0.98). Exposure to environmental tobacco smoke (ETS) during childhood increased the risk of bladder cancer (1.38, 1.00-1.90), whereas for ETS exposure as adult no effect was detected. The present study confirms the strong association between smoking and bladder cancer. The indication of a higher risk of bladder cancer for those who start smoking at a young age and for those exposed to ETS during childhood adds to the body of evidence suggesting that children are more sensitive to carcinogens than adults. 相似文献
6.
Tsilidis KK Allen NE Key TJ Bakken K Lund E Berrino F Fournier A Olsen A Tjønneland A Overvad K Boutron-Ruault MC Clavel-Chapelon F Byrnes G Chajes V Rinaldi S Chang-Claude J Kaaks R Bergmann M Boeing H Koumantaki Y Stasinopoulou G Trichopoulou A Palli D Tagliabue G Panico S Tumino R Vineis P Bueno-de-Mesquita HB van Duijnhoven FJ van Gils CH Peeters PH Rodríguez L González CA Sánchez MJ Chirlaque MD Barricarte A Dorronsoro M Borgquist S Manjer J van Guelpen B Hallmans G Rodwell SA Khaw KT 《British journal of cancer》2010,103(11):1755-1759
Background:
Oral contraceptive use and reproductive factors may initiate long-term changes to the hormonal milieu and thereby, possibly influence colorectal cancer risk.Methods:
We examined the association of hormonal and reproductive factors with risk of colorectal cancer among 337 802 women in the European Prospective Investigation into Cancer and Nutrition, of whom 1878 developed colorectal cancer.Results:
After stratification for center and age, and adjustment for body mass index, smoking, diabetes mellitus, physical activity and alcohol consumption, ever use of oral contraceptives was marginally inversely associated with colorectal cancer risk (hazard ratio (HR), 0.92; 95% confidence interval (CI), 0.83–1.02), although this association was stronger among post-menopausal women (HR, 0.84; 95% CI: 0.74–0.95). Duration of oral contraceptive use and reproductive factors, including age at menarche, age at menopause, type of menopause, ever having an abortion, parity, age at first full-term pregnancy and breastfeeding, were not associated with colorectal cancer risk.Conclusion:
Our findings provide limited support for a potential inverse association between oral contraceptives and colorectal cancer risk. 相似文献7.
Rohrmann S Grote VA Becker S Rinaldi S Tjønneland A Roswall N Grønbæk H Overvad K Boutron-Ruault MC Clavel-Chapelon F Racine A Teucher B Boeing H Drogan D Dilis V Lagiou P Trichopoulou A Palli D Tagliabue G Tumino R Vineis P Mattiello A Rodríguez L Duell EJ Molina-Montes E Dorronsoro M Huerta JM Ardanaz E Jeurnink S Peeters PH Lindkvist B Johansen D Sund M Ye W Khaw KT Wareham NJ Allen NE Crowe FL Fedirko V Jenab M Michaud DS Norat T Riboli E Bueno-de-Mesquita HB Kaaks R 《British journal of cancer》2012,106(5):1004-1010
Background:
Insulin-like growth factors (IGFs) and their binding proteins (BPs) regulate cell differentiation, proliferation and apoptosis, and may have a role in the aetiology of various cancers. Information on their role in pancreatic cancer is limited and was examined here in a case–control study nested within the European Prospective Investigation into Cancer and Nutrition.Methods:
Serum concentrations of IGF-I and IGFBP-3 were measured using enzyme-linked immunosorbent assays in 422 cases and 422 controls matched on age, sex, study centre, recruitment date, and time since last meal. Conditional logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounding variables.Results:
Neither circulating levels of IGF-I (OR=1.21, 95% CI 0.75–1.93 for top vs bottom quartile, P-trend 0.301), IGFBP-3 (OR=1.00, 95% CI 0.66–1.51, P-trend 0.79), nor the molar IGF-I/IGFBP-3 ratio, an indicator of free IGF-I level (OR=1.22, 95% CI 0.75–1.97, P-trend 0.27), were statistically significantly associated with the risk of pancreatic cancer. In a cross-classification, however, a high concentration of IGF-I with concurrently low levels of IGFBP-3 was related to an increased risk of pancreatic cancer (OR=1.72, 95% CI 1.05–2.83; P-interaction=0.154).Conclusion:
On the basis of these results, circulating levels of components of the IGF axis do not appear to be the risk factors for pancreatic cancer. However, on the basis of the results of a subanalysis, it cannot be excluded that a relatively large amount of IGF-1 together with very low levels of IGFBP-3 might still be associated with an increase in pancreatic cancer risk. 相似文献8.
Buckland G Travier N Agudo A Fonseca-Nunes A Navarro C Lagiou P Demetriou C Amiano P Dorronsoro M Chirlaque MD Huerta JM Molina E Pérez MJ Ardanaz E Moreno-Iribas C Quirós JR Naska A Trichopoulos D Giurdanella MC Tumino R Agnoli C Grioni S Panico S Mattiello A Masala G Sacerdote C Polidoro S Palli D Trichopoulou A González CA 《International journal of cancer. Journal international du cancer》2012,131(10):2465-2469
Although there is some evidence suggesting that olive oil could reduce breast cancer (BC) risk, the epidemiological data are still relatively limited, not entirely consistent and mainly based on case-control studies. Therefore, we prospectively assessed the association between olive oil and BC risk in postmenopausal women from the Mediterranean cohorts within the European Prospective Investigation into Cancer and Nutrition. The analysis included 62,284 postmenopausal women recruited from Spain, Italy and Greece who had complete dietary data (collected from validated country-specific dietary questionnaires). The risk of BC (overall and by hormone receptor subtypes) was assessed using hazards ratios (HRs) obtained from Cox proportional hazards regression, while adjusting for known BC risk factors. After a mean follow-up of 9 years, 1,256 women were diagnosed with a primary incident invasive BC. The multivariate HRs for BC risk by olive oil intake (highest vs. lowest tertile of g/day/2,000 kcal) were 1.07 (95% CI = 0.91-1.25) in the adjusted model, 1.06 (95% CI = 0.91-1.24) in the model additionally adjusted for reproductive-related factors and 1.10 (95% CI = 0.92-1.31) for the model additionally adjusted for dietary factors. There was no association between olive oil and risk of estrogen or progesterone receptor-positive tumors, but a suggestion of a negative association with estrogens and progesterone receptor-negative tumors. The results from our prospective study showed that olive oil consumption during adult life was not associated with the risk of BC. However, larger prospective studies are still needed to explore possible differences related to hormone receptor status. 相似文献
9.
Pischon T Lahmann PH Boeing H Tjønneland A Halkjaer J Overvad K Klipstein-Grobusch K Linseisen J Becker N Trichopoulou A Benetou V Trichopoulos D Sieri S Palli D Tumino R Vineis P Panico S Monninkhof E Peeters PH Bueno-de-Mesquita HB Büchner FL Ljungberg B Hallmans G Berglund G Gonzalez CA Dorronsoro M Gurrea AB Navarro C Martinez C Quirós JR Roddam A Allen N Bingham S Khaw KT Kaaks R Norat T Slimani N Riboli E 《International journal of cancer. Journal international du cancer》2006,118(3):728-738
Previous studies suggest that obesity is related to increased risk of renal cell carcinoma (RCC); however, only a few studies report on measures of central vs. peripheral adiposity. We examined the association between anthropometric measures, including waist and hip circumference and RCC risk among 348,550 men and women free of cancer at baseline from 8 countries of the European Prospective Investigation into Cancer and Nutrition (EPIC). During 6.0 years of follow-up we identified 287 incident cases of RCC. Relative risks were calculated using Cox regression, stratified by age and study center and adjusted for smoking status, education, alcohol consumption, physical activity, menopausal status, and hormone replacement therapy use. Among women, an increased risk of RCC was conferred by body weight (relative risk [RR] in highest vs. lowest quintile = 2.13; 95% confidence interval [CI] = 1.16-3.90; p-trend = 0.003), body mass index (BMI) (RR = 2.25; 95% CI = 1.14-4.44; p-trend = 0.009), and waist (RR = 1.67; 95% CI = 0.94-2.98; p-trend = 0.003) and hip circumference (RR = 2.30; 95% CI = 1.22-4.34; p-trend = 0.01); however, waist and hip circumference were no longer significant after controlling for body weight. Among men, hip circumference (RR = 0.44; 95% CI = 0.20-0.98; p-trend = 0.03) was related significantly to decreased RCC risk only after accounting for body weight. Height was not related significantly to RCC risk. Our findings suggest that obesity is related to increased risk of RCC irrespective of fat distribution among women, whereas low hip circumference is related to increased RCC risk among men. Our data give further credence to public health efforts aiming to reduce the prevalence of obesity to prevent RCC, in addition to other chronic diseases. 相似文献
10.
Tsilidis KK Allen NE Key TJ Dossus L Lukanova A Bakken K Lund E Fournier A Overvad K Hansen L Tjønneland A Fedirko V Rinaldi S Romieu I Clavel-Chapelon F Engel P Kaaks R Schütze M Steffen A Bamia C Trichopoulou A Zylis D Masala G Pala V Galasso R Tumino R Sacerdote C Bueno-de-Mesquita HB van Duijnhoven FJ Braem MG Onland-Moret NC Gram IT Rodríguez L Travier N Sánchez MJ Huerta JM Ardanaz E Larrañaga N Jirström K Manjer J Idahl A Ohlson N Khaw KT Wareham N Mouw T Norat T Riboli E 《British journal of cancer》2011,105(9):1436-1442
Background:
It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear.Methods:
We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 327 396 eligible women, 878 developed ovarian cancer over an average of 9 years. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models stratified by centre and age, and adjusted for smoking status, body mass index, unilateral ovariectomy, simple hysterectomy, menopausal hormone therapy, and mutually adjusted for age at menarche, age at menopause, number of full-term pregnancies and duration of oral contraceptive use.Results:
Women who used oral contraceptives for 10 or more years had a significant 45% (HR, 0.55; 95% CI, 0.41–0.75) lower risk compared with users of 1 year or less (P-trend, <0.01). Compared with nulliparous women, parous women had a 29% (HR, 0.71; 95% CI, 0.59–0.87) lower risk, with an 8% reduction in risk for each additional pregnancy. A high age at menopause was associated with a higher risk of ovarian cancer (>52 vs ⩽45 years: HR, 1.46; 95% CI, 1.06–1.99; P-trend, 0.02). Age at menarche, age at first full-term pregnancy, incomplete pregnancies and breastfeeding were not associated with risk.Conclusion:
This study shows a strong protective association of oral contraceptives and parity with ovarian cancer risk, a higher risk with a late age at menopause, and no association with other reproductive factors. 相似文献11.
Yahya Mahamat-Saleh Marie Al-Rahmoun Gianluca Severi Reza Ghiasvand Marit B. Veierod Saverio Caini Domenico Palli Edoardo Botteri Carlotta Sacerdote Fulvio Ricceri Marko Lukic Maria J. Sánchez Valeria Pala Rosario Tumino Paolo Chiodini Pilar Amiano Sandra Colorado-Yohar María-Dolores Chirlaque Eva Ardanaz Catalina Bonet Verena Katzke Rudolf Kaaks Matthias B. Schulze Kim Overvad Christina C. Dahm Christian S. Antoniussen Anne Tjønneland Cecilie Kyrø Bas Bueno-de-Mesquita Jonas Manjer Malin Jansson Anders Esberg Nagisa Mori Pietro Ferrari Elisabete Weiderpass Marie-Christine Boutron-Ruault Marina Kvaskoff 《International journal of cancer. Journal international du cancer》2023,152(3):348-362
Experimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country-specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal-cell carcinoma (BCC): n = 8711; squamous-cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow-up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1-4.9 g/day: HR = 1.44, 95% CI = 1.17-1.77; Ptrend = .001), BCC (HR = 1.12, 95% CI = 1.01-1.23; Ptrend = .04), and melanoma risks in men (HR = 1.17, 95% CI = 0.95-1.44; Ptrend = .17), while associations were more modest in women (SCC: HR = 1.09, 95% CI = 0.90-1.30; Ptrend = .13; BCC: HR = 1.08, 95% CI = 1.00-1.17, Ptrend = .03; melanoma: HR = 0.93, 95% CI = 0.80-1.08, Ptrend = .13). Associations were similar for lifetime alcohol intake, with an attenuated linear trend. Lifetime liquor/spirit intake was positively associated with melanoma (fourth vs first quartile: HR = 1.47, 95% CI = 1.08-1.99; Ptrend = .0009) and BCC risks in men (HR = 1.17, 95% CI = 1.04-1.31; Ptrend = .14). Baseline and lifetime intakes of wine were associated with BCC risk (HR = 1.25 in men; HR = 1.11-1.12; in women). No statistically significant associations were found between beverage types and SCC risk. Intake of beer was not associated with skin cancer risk. Our study suggests positive relationships between alcohol intake and skin cancer risk, which may have important implications for the primary prevention of skin cancer. 相似文献
12.
González CA Pera G Agudo A Palli D Krogh V Vineis P Tumino R Panico S Berglund G Simán H Nyrén O Agren A Martinez C Dorronsoro M Barricarte A Tormo MJ Quiros JR Allen N Bingham S Day N Miller A Nagel G Boeing H Overvad K Tjonneland A Bueno-De-Mesquita HB Boshuizen HC Peeters P Numans M Clavel-Chapelon F Helen I Agapitos E Lund E Fahey M Saracci R Kaaks R Riboli E 《International journal of cancer. Journal international du cancer》2003,107(4):629-634
Smoking has recently been recognised as causally associated with the development of gastric cancer (GC). However, evidence on the effect by sex, duration and intensity of smoking, anatomic subsite and cessation of smoking is limited. Our objective was to assess the relation between tobacco use and GC incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC). We studied data from 521,468 individuals recruited from 10 European countries taking part in the EPIC study. Participants completed lifestyle questionnaires that included questions on lifetime consumption of tobacco and diet in 1991-1998. Participants were followed until September 2002, and during that period 305 cases of stomach cancer were identified. After exclusions, 274 were eligible for the analysis, using the Cox proportional hazard model. After adjustment for educational level, consumption of fresh fruit, vegetables and preserved meat, alcohol intake and body mass index (BMI), there was a significant association between cigarette smoking and gastric cancer risk: the hazard ratio (HR) for ever smokers was 1.45 (95% confidence interval [CI] = 1.08-1.94). The HR of current cigarette smoking was 1.73 (95% CI = 1.06-2.83) in males and 1.87 (95% CI = 1.12-3.12) in females. Hazard ratios increased with intensity and duration of cigarette smoked. A significant decrease of risk was observed after 10 years of quitting smoking. A preliminary analysis of 121 cases with identified anatomic site showed that current cigarette smokers had a higher HR of GC in the cardia (HR = 4.10) than in the distal part of the stomach (HR = 1.94). In this cohort, 17.6 % (95% CI = 10.5-29.5 %) of GC cases may be attributable to smoking. Findings from this large study support the causal relation between smoking and gastric cancer in this European population. Stomach cancer should be added to the burden of diseases caused by smoking. 相似文献
13.
Mireia Obón-Santacana Leila Luján-Barroso Heinz Freisling Sabine Naudin Marie-Christine Boutron-Ruault Francesca Romana Mancini Vinciane Rebours Tilman Kühn Verena Katzke Heiner Boeing Anne Tjønneland Anja Olsen Kim Overvad Cristina Lasheras Miguel Rodríguez-Barranco Pilar Amiano Carmen Santiuste Eva Ardanaz Kay-Thee Khaw Nicholas J. Wareham Julie A. Schmidt Dagfinn Aune Antonia Trichopoulou Paschalis Thriskos Eleni Peppa Giovanna Masala Sara Grioni Rosario Tumino Salvatore Panico Bas Bueno-de-Mesquita Veronica Sciannameo Roel Vermeulen Emily Sonestedt Malin Sund Elisabete Weiderpass Guri Skeie Carlos A. González Elio Riboli Eric J. Duell 《International journal of cancer. Journal international du cancer》2020,146(1):76-84
Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country-specific dietary questionnaires. After a mean follow-up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72–1.10; p-trend = 0.70). Furthermore, no evidence for effect-measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk. 相似文献
14.
The literature from 1990 to 2003 on the relation between coffee, decaffeinated coffee, tea and colorectal cancer risk has been reviewed. For the relation with coffee, three cohort (517 total cases) and nine case-control studies (7555 cases) analysed colon cancer; three cohort (307 cases) and four case-control studies (2704 cases) rectal cancer; six case-control studies (854 cases) colorectal cancer. For colon cancer most case-control studies found risk estimates below unity; the results are less clear for cohort studies. No relation emerged for rectal cancer. A meta-analysis, including five cohort and twelve case-control studies, reported a pooled relative risk of 0.76 (significant). Any methodological artefact is unlikely to account for the consistent inverse association in different countries and settings. Plausible biological explanations include coffee-related reductions of cholesterol, bile acids and neutral sterol secretion in the colon; antimutagenic properties of selected coffee components; increased colonic motility. Decaffeinated coffee was not related to either colon or rectal cancer in three case-control studies. No overall association between tea and either colon or rectal cancer risk emerged in seven cohort (1756 total cases of colon, 759 of rectal and 60 of colorectal cancer) and 12 case-control studies (8058 cases of colon, 4865 of rectal, 604 of colorectal cancer). 相似文献
15.
Montella M Polesel J La Vecchia C Dal Maso L Crispo A Crovatto M Casarin P Izzo F Tommasi LG Talamini R Franceschi S 《International journal of cancer. Journal international du cancer》2007,120(7):1555-1559
The role of coffee in the aetiology of hepatocellular carcinoma has raised great interest. In Italy, coffee consumption is high, thus allowing the investigation of the topic over a broad range of consumption. A hospital-based case-control study was conducted in Italy in 1999-2002, including 185 incidents, histologically confirmed cases of hepatocellular carcinoma aged 43-84 years. Controls were 412 subjects admitted to the same hospitals' networks for acute, non-neoplastic diseases unrelated to diet. Coffee and tea consumption were assessed using a validated food-frequency questionnaire. Odds ratios (ORs) and corresponding the 95% confidence intervals (CI) were computed using unconditional multiple logistic regression, adjusting for hepatitis viruses seropositivity, alcohol intake, smoking habits and other potential confounding factors. Compared to people who drunk <14 cups/week of coffee, the risk of hepatocellular carcinoma decreased for increasing levels of consumption (OR=0.4, 95% CI: 0.2-1.1 for >or=28 cups/week, p for trend = 0.02). In the present study, inverse relations were observed across strata of hepatitis C and, B virus infections and alcohol drinking. No significant association emerged with consumption of decaffeinated coffee (OR=0.7, 95% CI=0.2-2.5) or tea (OR=1.4, 95% CI=0.8-2.7). The present study supports the hypothesis of a favourable effect of coffee, though not decaffeinated coffee and tea, on the risk on hepatocellular carcinoma. 相似文献
16.
Verheus M Peeters PH Rinaldi S Dossus L Biessy C Olsen A Tjønneland A Overvad K Jeppesen M Clavel-Chapelon F Téhard B Nagel G Linseisen J Boeing H Lahmann PH Arvaniti A Psaltopoulou T Trichopoulou A Palli D Tumino R Panico S Sacerdote C Sieri S van Gils CH Bueno-de-Mesquita BH González CA Ardanaz E Larranaga N Garcia CM Navarro C Quirós JR Key T Allen N Bingham S Khaw KT Slimani N Riboli E Kaaks R 《International journal of cancer. Journal international du cancer》2006,119(3):659-667
It has been hypothesized that chronic hyperinsulinemia, a major metabolic consequence of physical inactivity and excess weight, might increase breast cancer risk by direct effects on breast tissue or indirectly by increasing bioavailable levels of testosterone and estradiol. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we measured serum levels of C-peptide--a marker for pancreatic insulin secretion--in a total of 1,141 incident cases of breast cancer and 2,204 matched control subjects. Additional measurements were made of serum sex hormone binding globulin (SHBG) and sex steroids. Conditional logistic regression models were used to estimate breast cancer risk for different levels of C-peptide. C-peptide was inversely correlated with SHBG and hence directly correlated with free testosterone among both pre and postmenopausal women. C-peptide and free estradiol also correlated positively, but only among postmenopausal women. Elevated serum C-peptide levels were associated with a nonsignificant reduced risk of breast cancer diagnosed up to the age of 50 years [odds ratio (OR)=0.70, (95% confidence interval (CI), 0.39-1.24); ptrend=0.05]. By contrast, higher levels of C-peptide were associated with an increase of breast cancer risk among women above 60 years of age, however only among those women who had provided a blood sample under nonfasting conditions [OR=2.03, (95% CI, 1.20-3.43); ptrend=0.01]. Our results do not support the hypothesis that chronic hyperinsulinemia generally increases breast cancer risk, independently of age. Nevertheless, among older, postmenopausal women, hyperinsulinemia might contribute to increasing breast cancer risk. 相似文献
17.
Jagtap D Rosenberg CA Martin LW Pettinger M Khandekar J Lane D Ockene I Simon MS 《Cancer》2012,118(20):5124-5131
BACKGROUND:
Melanoma is the most lethal form of skin cancer, with an estimated 68,130 new cases and 8700 deaths in the United States in 2010. The increasing incidence and high death rate associated with metastatic disease support the need to focus on prevention. The authors used data from the Women's Health Initiative (WHI) to assess whether 3‐hydroxy‐3 methylglutaryl coenzyme A inhibitors (statins) are associated with a decreased risk of melanoma.METHODS:
The study population consisted of 119,726 postmenopausal white women, in which 1099 cases of malignant melanoma were identified over an average (±standard deviation) of 11.6 ± 3.2 years. All diagnoses were confirmed by medical record review and pathology reports. Information on statin use was collected at baseline and during follow‐up. Self‐administered and interview‐administered questionnaires were used to collect information on other risk factors. Cox proportional hazards regression was used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs). Analyses investigated the association of any statin use, type, potency, lipophilic status, and duration of use with melanoma.RESULTS:
Statins were used by 8824 women (7.4%) at baseline. The annualized rate of melanoma was 0.09% among statin users and 0.09% among nonusers The multivariable adjusted HR for statin users compared with nonusers was 1.14 (95% CI, 0.91‐1.43). There were no significant differences in risk based on statin type, potency, category, duration, or in time‐dependent models.CONCLUSIONS:
There was no significant association between statin use and melanoma risk among postmenopausal women in the WHI. Cancer 2012. © 2012 American Cancer Society. 相似文献18.
《British journal of cancer》2014,111(5):987-997
Background:
Three prospective studies have evaluated the association between dietary acrylamide intake and endometrial cancer (EC) risk with inconsistent results. The objective of this study was to evaluate the association between acrylamide intake and EC risk: for overall EC, for type-I EC, and in never smokers and never users of oral contraceptives (OCs). Smoking is a source of acrylamide, and OC use is a protective factor for EC risk.Methods:
Cox regression was used to estimate hazard ratios (HRs) for the association between acrylamide intake and EC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Acrylamide intake was estimated from the EU acrylamide monitoring database, which was matched with EPIC questionnaire-based food consumption data. Acrylamide intake was energy adjusted using the residual method.Results:
No associations were observed between acrylamide intake and overall EC (n=1382) or type-I EC risk (n=627). We observed increasing relative risks for type-I EC with increasing acrylamide intake among women who both never smoked and were non-users of OCs (HRQ5vsQ1: 1.97, 95% CI: 1.08–3.62; likelihood ratio test (LRT) P-value: 0.01, n=203).Conclusions:
Dietary intake of acrylamide was not associated with overall or type-I EC risk; however, positive associations with type I were observed in women who were both non-users of OCs and never smokers. 相似文献19.
Tjønneland A Christensen J Olsen A Stripp C Thomsen BL Overvad K Peeters PH van Gils CH Bueno-de-Mesquita HB Ocké MC Thiebaut A Fournier A Clavel-Chapelon F Berrino F Palli D Tumino R Panico S Vineis P Agudo A Ardanaz E Martinez-Garcia C Amiano P Navarro C Quirós JR Key TJ Reeves G Khaw KT Bingham S Trichopoulou A Trichopoulos D Naska A Nagel G Chang-Claude J Boeing H Lahmann PH Manjer J Wirfält E Hallmans G Johansson I Lund E Skeie G Hjartåker A Ferrari P Slimani N Kaaks R Riboli E 《Cancer causes & control : CCC》2007,18(4):361-373
Objective Most epidemiologic studies have suggested an increased risk of breast cancer with increasing alcohol intake. Using data from
274,688 women participating in the European Prospective Investigation into Cancer and Nutrition study (EPIC), we investigated
the relation between alcohol intake and the risk of breast cancer.
Methods Incidence rate ratios (IRRs) based on Cox proportional hazard models were calculated using reported intake of alcohol, recent
(at baseline) and lifetime exposure. We adjusted for known risk factors and stratified according to study center as well as
potentially modifying host factors.
Results During 6.4 years of follow up, 4,285 invasive cases of breast cancer within the age group 35–75 years were identified. For
all countries together the IRR per 10 g/day higher recent alcohol intake (continuous) was 1.03 (95% confidence interval (CI):
1.01–1.05). When adjusted, no association was seen between lifetime alcohol intake and risk of breast cancer. No difference
in risk was shown between users and non-users of HRT, and there was no significant interaction between alcohol intake and
BMI, HRT or dietary folate.
Conclusion This large European study supports previous findings that recent alcohol intake increases the risk of breast cancer. 相似文献
20.
Nina Føns Johnsen Anne Tjønneland Birthe L.R. Thomsen Jane Christensen Steffen Loft Christine Friedenreich Timothy J. Key Naomi E. Allen Petra H. Lahmann Lotte Mejlvig Kim Overvad Rudolf Kaaks Sabine Rohrmann Heiner Boing Gesthimani Misirli Antonia Trichopoulou Dimosthenis Zylis Rosario Tumino Valeria Pala H. Bas Bueno‐de‐Mesquita Lambertus A. Kiemeney Laudina Rodríguez Suárez Carlos A. Gonzalez Maria‐José Sánchez José María Huerta Aurelio Barricarte Gurrea Jonas Manjer Elisabet Wirfält Kay‐Tee Khaw Nick Wareham Paolo Boffetta Lars Egevad Sabina Rinaldi Elio Riboli 《International journal of cancer. Journal international du cancer》2009,125(4):902-908
The evidence concerning the possible association between physical activity and the risk of prostate cancer is inconsistent and additional data are needed. We examined the association between risk of prostate cancer and physical activity at work and in leisure time in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. In our study, including 127,923 men aged 20–97 years from 8 European countries, 2,458 cases of prostate cancer were identified during 8.5 years of followup. Using the Cox proportional hazards model, we investigated the associations between prostate cancer incidence rate and occupational activity and leisure time activity in terms of participation in sports, cycling, walking and gardening; a metabolic equivalent (MET) score based on weekly time spent on the 4 activities; and a physical activity index. MET hours per week of leisure time activity, higher score in the physical activity index, participation in any of the 4 leisure time activities, and the number of leisure time activities in which the participants were active were not associated with prostate cancer incidence. However, higher level of occupational physical activity was associated with lower risk of advanced stage prostate cancer (ptrend = 0.024). In conclusion, our data support the hypothesis of an inverse association between advanced prostate cancer risk and occupational physical activity, but we found no support for an association between prostate cancer risk and leisure time physical activity. © 2009 UICC 相似文献